IDH1 mutation leads to the increase of 2-hydroxyglutarate (2-HG), and the loss of 5hmC is partly mediated by the decrease 2-HG dehydrogenase (L2-HGDH), which has tumor inhibitory effects (36). This evidence concerns the gene IDH1 and neoplasm.